Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 830
Guide Official Revision Description Reason for Update
Version Date Number Of Change
June 1, 2023, Review
Memorandum - Janssen
COVID-19 Vaccine (fda.gov)
2023 06/28/2023 4. Medical Policy In Item 48. General
Systemic, Endocrine
Disorders, CACI –
Hypothyroidism Worksheet
revised to clarify that TSH
must be less than 10
(uIU/mL or mlU/L) within the
last one year to be CACI
eligible. TSH of 10 or higher
must be deferred.
2023 06/28/2023 5. Medical Policy In General Information,
Classes of Medical
Certificate, revised to clarify
that Balloon Pilots exercising
Commercial Pilot Privileges,
other than instructional flight,
must hold at least a Class II
FAA Medical Certificate.
2023 06/28/2023 6. Administrative Added Frequently Used
Pages document. Resource
identifies and provides quick
access to information most
often requested.
2023 06/28/2023 7. Errata In Item 35. Lungs and Chest,
COPD Status Summary,
corrected “primary function”
to “pulmonary function” test.
2023 06/28/2023 8. Errata In Item 47. Psychiatric, Use
of Antidepressant
Medications, SSRI-Decision
Path-I and SSRI-Decision
Path-II. Clarified Wellbutrin –
Extended Release is [XL] not
[EX].
2023 05/31/2023 1. Medical Policy In Item 47. Psychiatric, Use
of Antidepressant
Medications, revised
medications list to include
bupropion (Wellbutrin –
Extended Release [EX] and
Sustained Release [SR]).
Also removed language
referring to “four” specific
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
